Iterum TherapeuticsITRMF
13F holders, Q3 2025 (September 30)4holders +1
2new positions
1sold out
$0.67avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Iterum Therapeutics PLC (ITRMF) in their 13F filings, up 1 from Q2 2025. 2 opened new positions and 1 sold out. The largest holders were Captrust Financial Advisors ($75K), Gen-Wealth Partners Inc ($55K) and Blue Bell Private Wealth Management, LLC ($44).
- Company
- Iterum Therapeutics PLC
- CUSIP
- G6333L101
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $55K |
| Exits | 1 | $76K |
All 13F filers, Q2 2025 → Q3 2025: 182,213 shares bought and 76,047 shares sold, net +106,166 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Captrust Financial Advisors | 0.00% | Add +870.4% | 111,600 | $75K |
| Gen-Wealth Partners Inc | 0.02% | New | 82,047 | $55K |
| Blue Bell Private Wealth Management, LLC | 0.00% | No change | 66 | $44 |
| Cypress Capital Management LLC (WY) | 0.00% | New | 66 | $44 |
"% of holder's portfolio" is ITRMF's weight in each manager's 13F, not the share of Iterum Therapeutics PLC the manager owns.